BlueStone Venture Partners is a life science venture capital fund investing in entrepreneurial companies.
The fund provides strategic capital and support to early-stage life science companies, primarily in Series A and Series B equity rounds. It focuses on medical devices, health IT, advanced materials, and molecular diagnostics.
Mara Aspinall
and Thomas Nickoloff launched the venture capital fund in Tucson, Arizona in 2018.